Joachim Grevel

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 8

Top Venues

CPT: pharmacometrics & systems pharmacology

Molecular cancer therapeutics

BAST Inc Limited

Ludwig-Maximilians-Universitat Munchen (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

BAST Inc Limited Oct 01 2010

United Kingdom

Scientific Director

Education History

Ludwig-Maximilians-Universitat Munchen Sep 01 1975 - Feb 28 1982

Germany

PHD :: Faculty of Chemistry and Pharmacy

Publications

Joachim Grevel, Joshua Veasy, Blesson Chacko
Application of multistate modeling to clinical data analysis. CPT: pharmacometrics & systems pharmacology 13 (4) (2024)
Joachim Grevel, Joshua Veasy, Blesson Chacko
Application of multistate modeling to clinical data analysis. CPT: pharmacometrics & systems pharmacology (2024)
Joachim Grevel, Joshua Veasy, Blesson Chacko
Application of multistate modeling to clinical data analysis. CPT: pharmacometrics & systems pharmacology 13 (4) (2024)
Joachim Grevel, Joshua Veasy, Blesson Chacko
Application of multistate modeling to clinical data analysis. CPT: pharmacometrics & systems pharmacology 13 (4) (2024)
Joachim Grevel, Joshua Veasy, Blesson Chacko
Application of multistate modeling to clinical data analysis. CPT: pharmacometrics & systems pharmacology 13 (4) (2024)
Joachim Grevel, Joshua Veasy, Blesson Chacko
Application of multistate modeling to clinical data analysis. CPT: pharmacometrics & systems pharmacology 13 (4) (2024)
Joachim Grevel, Joshua Veasy, Blesson Chacko
Application of multistate modeling to clinical data analysis. CPT: pharmacometrics & systems pharmacology 13 (4) (2024)
Franck Morschhauser, Jean-Pascal Machiels, Gilles Salles, Sylvie Rottey, Simon A J Rule, David Cunningham, Frederic Peyrade, Christophe Fruchart, Hendrik-Tobias Arkenau, Isabelle Genvresse, Li Liu, Karl Köchert, Kui Shen, Christoph Kneip, Carol E Peña, Joachim Grevel, Jun Zhang, Galia Cisternas, Susanne Reschke, Camille Granvil, Ahmad Awada
On-Target Pharmacodynamic Activity of the PI3K Inhibitor Copanlisib in Paired Biopsies from Patients with Malignant Lymphoma and Advanced Solid Tumors. Molecular cancer therapeutics 19 (2) (2019)

Joachim Grevel.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Joachim Grevel